Yang Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yang Ma has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Di Li
Department of Hand and Podiatric Surgery Orthopedic Center First Hospital of Jilin University Changchun P. R. China
1 shared publication - Jianxun Ding
Chinese Academy of Sciences
1 shared publication - Shixian Liu
Key Laboratory of Polymer Ecomaterials Changchun Institute of Applied Chemistry Chinese Academy of Sciences 5625 Renmin Street Changchun 130022 P. R. China
1 shared publication - Siqi Liu
Key Laboratory of Polymer Ecomaterials Changchun Institute of Applied Chemistry Chinese Academy of Sciences 5625 Renmin Street Changchun 130022 P. R. China
1 shared publication - Yahui Liu
Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, China
1 shared publication
Latest Publications
- 28 April 2023
- Published by Wiley in Small Methods
- Vol. 7 (5) , e2300204
Biomaterials That Induce Immunogenic Cell Death
The immune system takes part in most physiological and pathological processes of the body, including the occurrence and development of cancer. Immunotherapy provides a promising modality for inhibition and even the cure of cancer. During immunotherapy, the immunogenic cell death (ICD) of tumor cells induced by chemotherapy, radiotherapy, phototherapy, bioactive materials, and so forth, triggers a series of cellular responses by causing the release of tumor‐associated antigens and damage‐associated molecular patterns, which ultimately activate innate and adaptive immune responses. Among them, the ICD‐induced biomaterials attract increasing conditions as a benefit of biosafety and multifunctional modifications. This Review summarizes the research progress in biomaterials for inducing ICD via triggering endoplasmic reticulum oxidative stress, mitochondrial dysfunction, and cell membrane rupture and discusses the application prospects of ICD‐inducing biomaterials in clinical practice for cancer immunotherapy.
- 28 April 2023
- Published by Wiley in Small Methods
- Vol. 7 (5) , e2300204
Biomaterials That Induce Immunogenic Cell Death
The immune system takes part in most physiological and pathological processes of the body, including the occurrence and development of cancer. Immunotherapy provides a promising modality for inhibition and even the cure of cancer. During immunotherapy, the immunogenic cell death (ICD) of tumor cells induced by chemotherapy, radiotherapy, phototherapy, bioactive materials, and so forth, triggers a series of cellular responses by causing the release of tumor‐associated antigens and damage‐associated molecular patterns, which ultimately activate innate and adaptive immune responses. Among them, the ICD‐induced biomaterials attract increasing conditions as a benefit of biosafety and multifunctional modifications. This Review summarizes the research progress in biomaterials for inducing ICD via triggering endoplasmic reticulum oxidative stress, mitochondrial dysfunction, and cell membrane rupture and discusses the application prospects of ICD‐inducing biomaterials in clinical practice for cancer immunotherapy.